CST8
gene geneOn this page
Also known as CRESCTES5
Summary
CST8 (cystatin 8, HGNC:2480) is a protein-coding gene on chromosome 20p11.21, encoding Cystatin-8 (O60676). Performs a specialized role during sperm development and maturation.
The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and the kininogens. The type 2 cystatin proteins are a class of cysteine proteinase inhibitors found in a variety of human fluids and secretions. The cystatin locus on chromosome 20 contains the majority of the type 2 cystatin genes and pseudogenes. This gene is located in the cystatin locus and encodes a protein similar to type 2 cystatins. The encoded protein exhibits highly tissue-specific expression in the reproductive tract, suggesting implicit roles in reproduction. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 10047 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 33 total
- MANE Select transcript:
NM_005492
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:2480 |
| Approved symbol | CST8 |
| Name | cystatin 8 |
| Location | 20p11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CRES, CTES5 |
| Ensembl gene | ENSG00000125815 |
| Ensembl biotype | protein_coding |
| OMIM | 608683 |
| Entrez | 10047 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000246012, ENST00000449810
RefSeq mRNA: 2 — MANE Select: NM_005492
NM_001281730, NM_005492
CCDS: CCDS13156
Canonical transcript exons
ENST00000246012 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000859436 | 23492958 | 23493071 |
| ENSE00000859437 | 23491525 | 23491898 |
| ENSE00001025776 | 23491117 | 23491342 |
| ENSE00001131377 | 23495831 | 23496010 |
Expression profiles
Bgee: expression breadth broad, 21 present calls, max score 86.34.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0383 / max 42.4020, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 183864 | 0.0383 | 3 |
Top tissues by expression
265 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.34 | gold quality |
| right testis | UBERON:0004534 | 83.61 | gold quality |
| left testis | UBERON:0004533 | 83.40 | gold quality |
| buccal mucosa cell | CL:0002336 | 82.88 | silver quality |
| testis | UBERON:0000473 | 80.54 | gold quality |
| sperm | CL:0000019 | 79.03 | silver quality |
| male germ cell | CL:0000015 | 78.55 | silver quality |
| hair follicle | UBERON:0002073 | 73.44 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 68.71 | gold quality |
| diaphragm | UBERON:0001103 | 68.61 | gold quality |
| tibialis anterior | UBERON:0001385 | 66.59 | silver quality |
| olfactory bulb | UBERON:0002264 | 65.42 | gold quality |
| type B pancreatic cell | CL:0000169 | 65.34 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 64.96 | gold quality |
| gingival epithelium | UBERON:0001949 | 64.47 | gold quality |
| squamous epithelium | UBERON:0006914 | 64.12 | gold quality |
| amniotic fluid | UBERON:0000173 | 63.66 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 62.63 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 62.56 | gold quality |
| deltoid | UBERON:0001476 | 62.20 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 61.83 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 61.69 | gold quality |
| gingiva | UBERON:0001828 | 61.28 | gold quality |
| thymus | UBERON:0002370 | 61.06 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 60.73 | gold quality |
| adult organism | UBERON:0007023 | 60.45 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 60.33 | gold quality |
| quadriceps femoris | UBERON:0001377 | 60.23 | gold quality |
| cerebellar vermis | UBERON:0004720 | 60.16 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 59.88 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.30 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): CEBPB
miRNA regulators (miRDB)
8 targeting CST8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-12122 | 99.56 | 69.33 | 1672 |
| HSA-MIR-1261 | 98.62 | 68.10 | 896 |
| HSA-MIR-3977 | 98.00 | 68.17 | 1500 |
| HSA-MIR-6515-5P | 97.08 | 65.48 | 1219 |
| HSA-MIR-490-5P | 96.75 | 65.81 | 661 |
Literature-anchored findings (GeneRIF, showing 2)
- studies show that cystatin-related epididymal spermatogenic protein is present in the sperm equatorial segment and becomes accessible to the extracellular environment during fertilization (PMID:12193387)
- We show with phylogenetic relations that the CTES genes are clustered into three original groups, a testatin, a Cres, and a CstL1 group (PMID:20565543)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:busm1-57f23.1 | ENSDARG00000074425 |
| mus_musculus | Cst8 | ENSMUSG00000027442 |
| rattus_norvegicus | Cst8 | ENSRNOG00000004989 |
| caenorhabditis_elegans | WBGENE00000534 | |
| caenorhabditis_elegans | WBGENE00000535 | |
| caenorhabditis_elegans | WBGENE00023486 |
Paralogs (11): CST7 (ENSG00000077984), CST9L (ENSG00000101435), CST3 (ENSG00000101439), CST4 (ENSG00000101441), CSTL1 (ENSG00000125823), CST11 (ENSG00000125831), CST5 (ENSG00000170367), CST2 (ENSG00000170369), CST1 (ENSG00000170373), CST9 (ENSG00000173335), CST6 (ENSG00000175315)
Protein
Protein identifiers
Cystatin-8 — O60676 (reviewed: O60676)
Alternative names: Cystatin-related epididymal spermatogenic protein
All UniProt accessions (3): O60676, A0A384MDQ4, A2A2N0
UniProt curated annotations — full annotation on UniProt →
Function. Performs a specialized role during sperm development and maturation.
Subcellular location. Secreted.
Tissue specificity. Proximal caput region of the epididymis. Lower expression in the testis. Within the testis it is localized to the elongating spermatids, whereas within the epididymis it is exclusively synthesized by the proximal caput epithelium.
Similarity. Belongs to the cystatin family.
RefSeq proteins (2): NP_001268659, NP_005483* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000010 | Cystatin_dom | Domain |
| IPR046350 | Cystatin_sf | Homologous_superfamily |
| IPR052691 | Sperm_Mat_Cystatin | Family |
Pfam: PF00031
UniProt features (9 total): glycosylation site 2, disulfide bond 2, sequence variant 2, signal peptide 1, chain 1, short sequence motif 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O60676-F1 | 87.12 | 0.70 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 95–105, 119–139
Glycosylation sites (2): 27, 39
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 48 (showing top):
GOCC_CELL_SURFACE, WEBER_METHYLATED_LCP_IN_SPERM_UP, GOMF_PEPTIDASE_REGULATOR_ACTIVITY, chr20p11, GOMF_ENZYME_INHIBITOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, YOSHIMURA_MAPK8_TARGETS_UP, GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY, GOMF_ENDOPEPTIDASE_REGULATOR_ACTIVITY, FOXN3_TARGET_GENES, SIPA1_TARGET_GENES, MIR1250_3P, MIR3977, MIR490_5P, NABA_ECM_REGULATORS
GO Biological Process (0):
GO Molecular Function (2): cysteine-type endopeptidase inhibitor activity (GO:0004869), peptidase inhibitor activity (GO:0030414)
GO Cellular Component (3): extracellular region (GO:0005576), cytoplasm (GO:0005737), cell surface (GO:0009986)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cysteine-type endopeptidase activity | 1 |
| endopeptidase inhibitor activity | 1 |
| enzyme inhibitor activity | 1 |
| peptidase activity | 1 |
| peptidase regulator activity | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
737 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CST8 | CST9 | Q5W186 | 753 |
| CST8 | CTPS1 | P17812 | 558 |
| CST8 | GATA1 | P15976 | 549 |
| CST8 | CEBPA | P49715 | 492 |
| CST8 | LCN8 | Q6JVE9 | 483 |
| CST8 | GZF1 | Q9H116 | 456 |
| CST8 | GHSR | Q92847 | 411 |
| CST8 | NXT1 | Q9UKK6 | 408 |
| CST8 | TMEM167B | Q9NRX6 | 384 |
| CST8 | ACSS1 | Q9NUB1 | 372 |
| CST8 | CST9L | Q9H4G1 | 371 |
| CST8 | RILPL1 | Q5EBL4 | 368 |
| CST8 | TMEM225 | Q6GV28 | 367 |
| CST8 | GALNT9 | Q9HCQ5 | 366 |
| CST8 | ECSCR | Q19T08 | 364 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM9C | NDC80 | psi-mi:“MI:0914”(association) | 0.670 |
| IQCF2 | TRAFD1 | psi-mi:“MI:0914”(association) | 0.350 |
| SPO16 | CST8 | psi-mi:“MI:0914”(association) | 0.350 |
| MGST2 | CST8 | psi-mi:“MI:0914”(association) | 0.350 |
| RGS5 | CST8 | psi-mi:“MI:0914”(association) | 0.350 |
| CDKN3 | CST8 | psi-mi:“MI:0914”(association) | 0.350 |
| CST8 | ITIH2 | psi-mi:“MI:0914”(association) | 0.350 |
| CST8 | HS3ST1 | psi-mi:“MI:0914”(association) | 0.350 |
| CST8 | VGF | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (44): ARMC8 (Affinity Capture-MS), CST8 (Affinity Capture-MS), LAMA3 (Affinity Capture-MS), TUBB8 (Affinity Capture-MS), TUBA1B (Affinity Capture-MS), CST8 (Affinity Capture-MS), B4GALT6 (Affinity Capture-MS), MKLN1 (Affinity Capture-MS), CST8 (Affinity Capture-MS), SPCS3 (Affinity Capture-MS), HEATR6 (Affinity Capture-MS), DDX19B (Affinity Capture-MS), KHK (Affinity Capture-MS), MAEA (Affinity Capture-MS), PXDN (Affinity Capture-MS)
ESM2 similar proteins: A0A0K0IP23, A0A1S3PBB7, A0A224AHH8, A0A3S6I186, A0A5C1J0Z8, A0A6B9KZ52, A1L015, A1L017, B1P1J3, B2Z450, B7PKZ1, B7PKZ2, D0NBV1, D0NBV4, E3P6N5, E3P6N6, E3P6N7, E3P6N9, E3P6P0, E3P6P1, E3P6P2, E3P6P4, J3RYX9, O60676, O88969, P01048, P08932, P08935, P0DXA0, P19313, P22085, P23779, P28325, P32766, P35481, P81714, P90698, Q15828, Q2XXN5, Q331K1
Diamond homologs: B2Z450, E3P6N3, E3P6N4, E3P6N5, E3P6N6, E3P6N7, E3P6N8, E3P6N9, E3P6P0, E3P6P1, E3P6P2, E3P6P3, E3P6P4, J3RYX9, J3SE80, O19092, O19093, O60676, O76096, O88969, O89098, O97862, P01034, P01035, P01036, P01037, P01038, P08935, P09228, P14841, P19313, P21460, P22085, P28325, P32766, P35481, P81061, P81714, P90698, Q15828
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
33 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
405 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:23493070:GG:G | donor_gain | 0.9900 |
| 20:23493071:GG:G | donor_gain | 0.9900 |
| 20:23491897:AGGTA:A | donor_loss | 0.9800 |
| 20:23491900:T:C | donor_loss | 0.9800 |
| 20:23495829:A:AG | acceptor_gain | 0.9800 |
| 20:23495830:G:GG | acceptor_gain | 0.9800 |
| 20:23495830:GA:G | acceptor_gain | 0.9800 |
| 20:23495830:GAA:G | acceptor_gain | 0.9800 |
| 20:23493071:GGTA:G | donor_loss | 0.9700 |
| 20:23495827:TCA:T | acceptor_loss | 0.9700 |
| 20:23495829:A:C | acceptor_loss | 0.9700 |
| 20:23495830:G:GA | acceptor_loss | 0.9700 |
| 20:23491856:G:GG | donor_gain | 0.9600 |
| 20:23492952:CAACA:C | acceptor_loss | 0.9500 |
| 20:23492953:AACAG:A | acceptor_loss | 0.9500 |
| 20:23492954:ACAG:A | acceptor_loss | 0.9500 |
| 20:23492955:CAGG:C | acceptor_loss | 0.9500 |
| 20:23492956:AGGT:A | acceptor_loss | 0.9500 |
| 20:23495757:G:GT | donor_gain | 0.9500 |
| 20:23495830:GAAA:G | acceptor_gain | 0.9400 |
| 20:23495830:GAAAT:G | acceptor_gain | 0.9300 |
| 20:23493076:G:C | donor_loss | 0.9100 |
| 20:23491855:A:AG | donor_gain | 0.9000 |
| 20:23491871:G:GA | donor_gain | 0.9000 |
| 20:23491204:G:GT | donor_gain | 0.8800 |
| 20:23491340:GGG:G | donor_gain | 0.8700 |
| 20:23491341:GGG:G | donor_gain | 0.8700 |
| 20:23493075:G:GC | donor_loss | 0.8700 |
| 20:23491203:GGGA:G | donor_gain | 0.8600 |
| 20:23491870:TGGTC:T | donor_gain | 0.8600 |
AlphaMissense
933 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:23495879:T:C | F132L | 0.978 |
| 20:23495881:C:A | F132L | 0.978 |
| 20:23495881:C:G | F132L | 0.978 |
| 20:23491863:T:C | F66L | 0.977 |
| 20:23491865:C:A | F66L | 0.977 |
| 20:23491865:C:G | F66L | 0.977 |
| 20:23491811:T:G | C48W | 0.975 |
| 20:23491818:T:C | F51L | 0.974 |
| 20:23491820:T:A | F51L | 0.974 |
| 20:23491820:T:G | F51L | 0.974 |
| 20:23495869:G:C | W128C | 0.972 |
| 20:23495869:G:T | W128C | 0.972 |
| 20:23491822:C:A | A52D | 0.968 |
| 20:23495847:T:G | F121C | 0.963 |
| 20:23493003:A:C | S93R | 0.961 |
| 20:23493005:C:A | S93R | 0.961 |
| 20:23493005:C:G | S93R | 0.961 |
| 20:23495846:T:C | F121L | 0.960 |
| 20:23495847:T:C | F121S | 0.960 |
| 20:23495848:T:A | F121L | 0.960 |
| 20:23495848:T:G | F121L | 0.960 |
| 20:23492977:A:C | Y84S | 0.955 |
| 20:23491809:T:C | C48R | 0.951 |
| 20:23495840:T:A | C119S | 0.951 |
| 20:23495841:G:C | C119S | 0.951 |
| 20:23492976:T:G | Y84D | 0.947 |
| 20:23492997:G:C | A91P | 0.947 |
| 20:23495867:T:A | W128R | 0.947 |
| 20:23495867:T:C | W128R | 0.947 |
| 20:23492976:T:C | Y84H | 0.943 |
dbSNP variants (sampled 300 via entrez): RS1000021993 (20:23500007 A>G,T), RS1000143913 (20:23498122 T>G), RS1000196691 (20:23498446 C>T), RS1000276092 (20:23505161 T>G), RS1000904377 (20:23494971 C>A,T), RS1001012619 (20:23489531 A>G), RS1001090710 (20:23501887 C>A,T), RS1001438598 (20:23501736 T>C), RS1001794715 (20:23507096 C>A,T), RS1001988261 (20:23504003 A>G), RS1002018846 (20:23497497 CT>C), RS1002069780 (20:23497751 T>C), RS1002354260 (20:23490654 G>A), RS1002708337 (20:23506722 C>T), RS1002762122 (20:23489939 C>T)
Disease associations
OMIM: gene MIM:608683 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Fluorouracil | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.